Genetics of Connective Tissue Disorders
Connective tissue disorders including hypermobile Ehlers-Danlos Syndrome (hEDS) and hypermobility spectrum disorders frequently co-occur with ME/CFS, POTS, and MCAS. Genetic variants in collagen, elastin, and extracellular matrix genes underlie connective tissue integrity.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Connective Tissue Disorders?
Connective tissue forms the structural scaffold of the body, including skin, tendons, ligaments, blood vessel walls, and organ capsules. Genetic variants in collagen genes (COL1A1, COL3A1, COL5A1), fibrillin (FBN1), elastin (ELN), and matrix metalloproteinases (MMPs) influence connective tissue strength and elasticity. Connective tissue disorders — particularly hypermobile EDS — are significantly over-represented in patients with ME/CFS, POTS, and MCAS, suggesting shared biological vulnerabilities. This triad of conditions (sometimes called the 'trifecta') may reflect underlying connective tissue fragility affecting blood vessel walls and autonomic nerve support structures.
Biological pathways commonly discussed in relation to Connective Tissue Disorders
Research into Connective Tissue Disorders and Hypermobility has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Collagen Synthesis
Collagen is the most abundant structural protein in the body. Variants in COL1A1, COL3A1, and COL5A1 affect collagen fibre assembly and mechanical properties of connective tissue.
Extracellular Matrix
The extracellular matrix (ECM) provides structural support and signalling context for cells. Fibronectin, laminin, and proteoglycan variants may alter ECM composition and mechanical properties.
Mmp Remodelling
Matrix metalloproteinases (MMP2, MMP9) degrade ECM components during tissue remodelling. Their inhibitors (TIMPs) regulate this process. Imbalance may contribute to tissue fragility or fibrosis.
Vascular Connective Tissue
Blood vessel walls rely on collagen and elastin for structural integrity. Variants in connective tissue genes may weaken vessel walls, contributing to vascular instability and POTS susceptibility.
Key genes studied in relation to Connective Tissue Disorders
The following genes have been studied in relation to Connective Tissue Disorders and Hypermobility. These genes span the biological pathways most commonly discussed in this area of research.
18 genes total studied in relation to Connective Tissue Disorders across the ChronicDNA dataset.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Connective Tissue Disorders. Each variant represents a position in the genome where individuals may carry different alleles.
27 variants total across genes studied in relation to Connective Tissue Disorders.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Connective Tissue Disorders.
This is not a diagnostic service. Genetic variants do not determine whether you have Connective Tissue Disorders, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Connective Tissue Disorders shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
What is the connection between connective tissue disorders and ME/CFS or POTS?
Hypermobile EDS, POTS, and MCAS frequently co-occur, forming what researchers sometimes call the 'trifecta'. Connective tissue fragility may weaken blood vessel walls and nerve support structures, contributing to orthostatic intolerance, dysautonomia, and mast cell vulnerability.
Which genes are studied in relation to connective tissue disorders?
Key genes include COL1A1, COL3A1, COL5A1, FBN1, ELN, TNXB, MMP2, MMP9, and TIMP1. Variants in these genes underlie conditions ranging from Marfan syndrome to hypermobile EDS.
Is hypermobile EDS genetic?
Hypermobile EDS (hEDS) is the most common but least understood EDS subtype. Unlike other EDS types, no single causative gene has been identified for hEDS — it is likely polygenic. Other EDS subtypes (classical, vascular) have known collagen gene variants.
Can Long COVID worsen connective tissue symptoms?
Some patients report worsening of connective tissue symptoms following COVID-19 infection. This may reflect immune-mediated matrix remodelling, mast cell activation, or autonomic changes that stress already-vulnerable connective tissue. This is an area of emerging research.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Connective Tissue Disorders and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
18 genes · 27 variants analysed in relation to Connective Tissue Disorders